Skip to main content
OpenTrials

Clinical trial condition

Hepadnaviridae Infections

Explore clinical trials studying Hepadnaviridae Infections. Study availability and eligibility vary by location and protocol.

1,149 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Hepadnaviridae Infections trial results

Completed

A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection

NCT04129554

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Cliniques Universitaires Saint Luc Brussels, Belgium
  • SGS Belgium NV Edegem, Belgium
  • UZ Antwerpen Edegem, Belgium
  • Universitair Ziekenhuis Gent Ghent, Belgium
View all 41 locations
View Trial Details
Completed

A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection

NCT03982186

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • The Office of Franco Felizarta, MD Bakersfield, California, United States
  • Ruane Clinical Research Group Inc Los Angeles, California, United States
  • Southern California GI and Liver Center San Clemente, California, United States
  • Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital Washington D.C., District of Columbia, United States
View all 108 locations
View Trial Details
Completed

A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis B

NCT03439488

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Republican Clinical Hospital Chisnau, Moldova
  • Auckland Clinical Services Auckland, New Zealand
  • Seoul National University Hospital Seoul, South Korea
  • Severance Hospital, Yonsei University Health System Seoul, South Korea
View Trial Details
Completed

A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B

NCT04426968

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • The fifth medical center of PLA Beijing, Beijing Municipality, China
  • Jilin Hepatobiliary Disease Hospital Changchun, China
  • The first hospital of Jilin University Changchun, China
  • Chizhou People's Hospital Chizhou, China
View Trial Details
Completed

This is a Phase 1 Study in Which Healthy Volunteers and Participants with Chronic HBV Infection Will Receive HT-101 or Placebo and Will Be Assessed for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity

NCT06746311

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Beijing Ditan Hospital Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital Beijing, Beijing Municipality, China
  • Nanfang Hospital Guangzhou, Guangdong, China
  • The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China
View Trial Details
Completed

Phase 1 Study of HT-102 Administered Subcustaneously in Healthy Participants and Patients with Chronic Hepatitis B for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity (only in Participants with Chronic HBV Infection)

NCT06744686

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou, Fujian, China
  • People's Hospital of Qingyuan Qingyuan, Guangdong, China
  • Luoyang Central Hospital Luoyang, Henan, China
  • The Sixth People's Hospital of Zhengzhou Zhengzhou, Henan, China
View Trial Details

Related conditions